|
Memórias do Instituto Oswaldo Cruz
Fundação Oswaldo Cruz, Fiocruz
ISSN: 1678-8060 EISSN: 1678-8060
Vol. 109, No. 6, 2014, pp. 838-845
|
Bioline Code: oc14124
Full paper language: English
Document type: View Point
Document available free of charge
|
|
Memórias do Instituto Oswaldo Cruz, Vol. 109, No. 6, 2014, pp. 838-845
en |
Oral bacillus Calmette-Guérin vaccine against tuberculosis: why not?
Monteiro-Maia, Renata & de Pinho, Rosa Teixeira
Abstract
The bacillus Calmette-Guérin (BCG) vaccine is the only licensed vaccine for human use against tuberculosis (TB). Although controversy exists about its efficacy, the BCG vaccine is able to protect newborns and children against disseminated forms of TB, but fails to protect adults against active forms of TB. In the last few years, interest in the mucosal delivery route for the vaccine has been increasing owing to its increased capacity to induce protective immune responses both in the mucosal and the systemic immune compartments. Here, we show the importance of this route of vaccination in newly developed vaccines, especially for vaccines against TB.
Keywords
vaccine; BCG; tuberculosis; mucosal; intradermal; oral
|
|
© Copyright 2014 - Memórias do Instituto Oswaldo Cruz Alternative site location: http://memorias.ioc.fiocruz.br
|
|